Analysis from business intelligence provider GBI Research – Type 1 Diabetes Mellitus Therapeutics in Major Developed Markets to 2021 – states that the global market value for T1DM treatment will rise from $4.2 billion in 2014 to $7.1 billion by 2021, at a robust Compound Annual Growth Rate (CAGR) of 7.9{20b543310651bf6f3679f07daa0e532ca50e05ab066d8bcfc12d35f979f65272}.

See original article:
T1DM therapeutics market expected to reach $7.1 billion by 2021

Scroll to Top